Abstract
Treatment with opioid agonists in vitro and in vivo has been shown to affect the function of the immune system. Several investigators have suggested that immune cells may express opioid receptors, but it had been very difficult to demonstrate their presence on these cells by direct binding assays. Our earlier studies have shown that macrophage progenitor cells are highly sensitive to morphine treatment in vitro and in vivo. In the current investigation, we determined, unequivocally, the expression of μ-opioid receptor related transcripts in rat peritoneal macrophages by reverse transcriptase-polymerase chain reaction (RT-PCR) studies. In order to further characterize the transcript, the RT-PCR product was cloned and sequenced. The sequence analyses indicate that the transcripts from rat peritoneal macrophages are identical to those for the μ-opioid receptor described in the rat brain. To further confirm the presence of μ-opioid receptors, immunoreactivity to an antiserum raised against the carboxyl terminal fifteen amino acid residues of the μ-opioid receptor was determined. These studies show for the first time that rat peritoneal macrophages express a μ-opioid receptor.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 563-574 |
| Number of pages | 12 |
| Journal | Biochemical and Biophysical Research Communications |
| Volume | 209 |
| Issue number | 2 |
| DOIs | |
| State | Published - Apr 17 1995 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Complementary DNA cloning of a μ-opioid receptor from rat pertitoneal macrophages'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS